You are here

Article Text

Article menu
Download PDFPDF
Community child health, public health, and epidemiology
Islet transplant: an option for childhood diabetes?
  1. E Hathout1,
  2. J Lakey2,
  3. J Shapiro3
  1. 1Director, Pediatric Diabetes Center and Chief, Division of Endocrinology and Diabetes, Loma Linda University Children’s Hospital, Loma Linda, USA
  2. 2Director, Clinical Islet Isolation Laboratory, University of Alberta
  3. 3Director, Clinical Islet Transplant Program and Clinical Research Chair in Transplantation, University of Alberta
  1. Correspondence to:
    Dr J Shapiro, Director, Clinical Islet Transplant Program, Clinical Research Chair in Transplantation (CIHR/Wyeth Canada), Roberts Centre, University of Alberta, 2000 College Plaza, 8215 112 St, Edmonton AB, Canada T6G 2C8;
    amjs{at}islet.ca

Abstract

Careful assessment of the safety and efficacy of islet transplantation should guide the selection process of a small number of children with type 1 diabetes who may be eligible for the procedure—some of whom are already receiving immunosuppression because of a previous transplant, others who are scheduled to receive de novo islet alone transplantation because of a life threatening risk of hypoglycemia. The outcomes of these initial investigations are predicted to shape the future boundaries of islet transplantation, diabetes, and transplantation.

  • islet transplant
  • diabetes

https://doi.org/10.1136/adc.88.7.591

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    Linked Articles

    • Atoms
      Atoms
      Howard Bauchner
      Archives of Disease in Childhood 2003; 88 557-557 Published Online First: 01 Jul 2003. doi: 10.1136/adc.88.7.557-a